Page last updated: 2024-08-21

isoxazoles and Carcinoma

isoxazoles has been researched along with Carcinoma in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19901 (11.11)18.7374
1990's0 (0.00)18.2507
2000's4 (44.44)29.6817
2010's4 (44.44)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dong, W; Liu, J; Qin, Y; Sun, W; Wang, Z; Zhang, H; Zhang, T1
Choi, MG; Ihm, SH; Kang, JG; Kim, CS; Kim, SH; Lee, SJ; Yoo, HJ1
Lin, W; Liu, BL; Pan, HL; Zhang, YQ1
Blassl, C; Djuzenova, CS; Flentje, M; Günther, N; Katzer, A; Kuger, S; Niewidok, N; Polat, B; Roloff, K; Sukhorukov, VL1
Aszalos, A; Cardarelli, C; Forte, R; Gottesman, MM; Kozar, M; Liang, XJ; Taylor, B; Wang, PC; Yin, JJ; Zhou, JW1
Bleichrodt, RP; Boerman, OC; Goldenberg, DM; Hendriks, T; Koppe, MJ; Oyen, WJ; Verhofstad, AA1
Kitamura, T; Matsuura, M; Mutoh, M; Niho, N; Sato, H; Sugimura, T; Takahashi, M; Wakabayashi, K1
Aherne, W; Barril, X; Box, G; Boxall, F; Boxall, K; Brough, PA; Cansfield, JE; Cheung, KM; de Haven Brandon, A; Drysdale, MJ; Dymock, B; Eccles, SA; Finch, H; Gowan, S; Hayes, A; Howes, R; Hubbard, RE; James, K; Jones, K; Kalusa, A; Martins, V; Massey, A; Matthews, TP; McDonald, E; Patterson, L; Pearl, L; Prodromou, C; Raynaud, FI; Rowlands, M; Sharp, SY; Surgenor, A; Urban, F; Valenti, M; Webb, P; Wood, M; Workman, P; Wright, L1
Cooney, DA; Kensler, TW; Reck, LJ1

Other Studies

9 other study(ies) available for isoxazoles and Carcinoma

ArticleYear
HSP90 inhibitor NVP-AUY922 induces cell apoptosis by disruption of the survivin in papillary thyroid carcinoma cells.
    Biochemical and biophysical research communications, 2017, May-27, Volume: 487, Issue:2

    Topics: Antineoplastic Agents; Apoptosis; Carcinoma; Carcinoma, Papillary; Cell Line, Tumor; Dose-Response Relationship, Drug; Down-Regulation; HSP90 Heat-Shock Proteins; Humans; Inhibitor of Apoptosis Proteins; Isoxazoles; Resorcinols; Signal Transduction; Survivin; Thyroid Cancer, Papillary; Thyroid Neoplasms

2017
The dipeptidyl peptidase-IV inhibitor gemigliptin alone or in combination with NVP-AUY922 has a cytotoxic activity in thyroid carcinoma cells.
    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2017, Volume: 39, Issue:10

    Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Carcinoma; Cell Line, Tumor; Cell Survival; Dipeptidyl-Peptidase IV Inhibitors; Drug Synergism; Flow Cytometry; Humans; Isoxazoles; Piperidones; Pyrimidines; Resorcinols; Signal Transduction; Thyroid Neoplasms

2017
Modulation of Nav1.8 by Lysophosphatidic Acid in the Induction of Bone Cancer Pain.
    Neuroscience bulletin, 2016, Volume: 32, Issue:5

    Topics: Animals; Biophysics; Bone Neoplasms; Cancer Pain; Carcinoma; Disease Models, Animal; Electric Stimulation; Enzyme Inhibitors; Female; Ganglia, Spinal; Gene Expression Regulation, Neoplastic; Hyperalgesia; Isoxazoles; Lysophospholipids; Membrane Potentials; NAV1.8 Voltage-Gated Sodium Channel; Neurons; Pain Measurement; Patch-Clamp Techniques; Propionates; Rats; Rats, Sprague-Dawley; Receptors, Lysophosphatidic Acid

2016
Hsp90 inhibitor NVP-AUY922 enhances radiation sensitivity of tumor cell lines under hypoxia.
    Cancer biology & therapy, 2012, Volume: 13, Issue:6

    Topics: Carcinoma; CDC2 Protein Kinase; Cell Cycle; Cell Hypoxia; Cell Line, Tumor; Cyclin-Dependent Kinase 4; DNA Damage; Glioblastoma; Histones; HSP70 Heat-Shock Proteins; HSP90 Heat-Shock Proteins; Humans; Isoxazoles; Lung Neoplasms; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-raf; Radiation-Sensitizing Agents; Radiation, Ionizing; Resorcinols

2012
Changes in biophysical parameters of plasma membranes influence cisplatin resistance of sensitive and resistant epidermal carcinoma cells.
    Experimental cell research, 2004, Feb-15, Volume: 293, Issue:2

    Topics: Carcinoma; Cell Division; Cell Line, Tumor; Cell Membrane; Cisplatin; Clone Cells; Cyclic N-Oxides; Drug Resistance, Neoplasm; Fatty Acids; HeLa Cells; Humans; Isoxazoles; Membrane Fluidity; Membrane Lipids; Membrane Potentials; Membrane Proteins; Neoplasms; Potassium Channels; Pyrimidinones

2004
Combination therapy using the cyclooxygenase-2 inhibitor Parecoxib and radioimmunotherapy in nude mice with small peritoneal metastases of colonic origin.
    Cancer immunology, immunotherapy : CII, 2006, Volume: 55, Issue:1

    Topics: Animals; Antibodies, Monoclonal; Carcinoma; Colonic Neoplasms; Cyclooxygenase Inhibitors; Iodine Radioisotopes; Isoxazoles; Male; Maximum Tolerated Dose; Mice; Mice, Inbred BALB C; Mice, Nude; Peritoneal Neoplasms; Radioimmunotherapy; Survival; Tissue Distribution; Transplantation, Heterologous

2006
Suppression of azoxymethane-induced colon cancer development in rats by a cyclooxygenase-1 selective inhibitor, mofezolac.
    Cancer science, 2006, Volume: 97, Issue:10

    Topics: Animals; Azoxymethane; Carcinoma; Colonic Neoplasms; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Isoxazoles; Male; Membrane Proteins; Rats; Rats, Inbred F344

2006
NVP-AUY922: a novel heat shock protein 90 inhibitor active against xenograft tumor growth, angiogenesis, and metastasis.
    Cancer research, 2008, Apr-15, Volume: 68, Issue:8

    Topics: Animals; Antineoplastic Agents; Carcinoma; Cell Cycle; Cell Division; Female; HSP90 Heat-Shock Proteins; Humans; Isoxazoles; Mice; Mice, Nude; Neoplasm Metastasis; Neovascularization, Pathologic; Resorcinols; Transplantation, Heterologous

2008
Therapeutic effects of acivicin and N-(phosphonacetyl)-L-aspartic acid in a biochemically designed trial against a N-(phosphonacetyl)-L-aspartic acid-resistant variant of the Lewis lung carcinoma.
    Cancer research, 1981, Volume: 41, Issue:3

    Topics: Animals; Aspartate Carbamoyltransferase; Aspartic Acid; Carbamoyl-Phosphate Synthase (Glutamine-Hydrolyzing); Carcinoma; Drug Therapy, Combination; Glycine; Isoxazoles; Ligases; Lung Neoplasms; Neoplasms, Experimental; Organophosphorus Compounds; Oxazoles; Phosphonoacetic Acid; Pyrimidines; Rats

1981